Financials
- Market Capitalization 447.63 M
- Employee 116
- Founded 2013
- CEO Shankar Musunuri
- Website www.ocugen.com
- Headquarter Delaware, United States
- FIGI BBG00194VJB1
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-5.88
市销率
106.63
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2969 | DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 6.91 USD | -0.43% | -5.60% | -14.80% | -22.18% | 444.59 M USD | ||
| 2972 | EVMN Evommune, Inc. Common Stock | 12.51 USD | +0.16% | -11.15% | +12.30% | -27.77% | 454.01 M USD | ||
| 2978 | AVIR Atea Pharmaceuticals, Inc. - common stock | 5.67 USD | +3.28% | +3.47% | +19.87% | +76.64% | 454.76 M USD | ||
| 2998 | PRLD Prelude Therapeutics Incorporated - Common Stock | 5.49 USD | 0.00% | -16.06% | +18.06% | +390.18% | 438.12 M USD |